rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-5-13
|
pubmed:abstractText |
Receptors for vasoactive intestinal polypeptide (VIP) have recently been suggested to play a key role in immunomodulation with genetically modified mice. However, it is not known whether changes in receptor gene regulation are involved in the pathogenesis of human immune disorders.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1099-105
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12743576-Dermatitis, Atopic,
pubmed-meshheading:12743576-Down-Regulation,
pubmed-meshheading:12743576-Gene Expression Regulation,
pubmed-meshheading:12743576-Humans,
pubmed-meshheading:12743576-Mast Cells,
pubmed-meshheading:12743576-RNA, Messenger,
pubmed-meshheading:12743576-Receptors, Vasoactive Intestinal Peptide,
pubmed-meshheading:12743576-Receptors, Vasoactive Intestinal Peptide, Type II,
pubmed-meshheading:12743576-Skin,
pubmed-meshheading:12743576-Vasoactive Intestinal Peptide
|
pubmed:year |
2003
|
pubmed:articleTitle |
Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis.
|
pubmed:affiliation |
Clinical Research Unit of Allergology, Department of Pediatric Pneumology and Immunology, Charité School of Medicine, Humboldt-University, Berlin, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|